businesspress24.com - Vetter expands its footprint in Asia Pacific region
 

Vetter expands its footprint in Asia Pacific region

ID: 1528162

Company establishes its presence in South Korea

(firmenpresse) - SONGDO, SOUTH KOREA and RAVENSBURG, GERMANY -- (Marketwired) -- 11/09/17 --





, one of the global leaders in , today announced the official opening of a new branch office in South Korea. The new is located within the biologics cluster which is often referred to as a ''sweet spot'' by the industry as it houses numerous prominent biopharmaceutical companies and service providers.

Strengthening its global footprint in the Asia Pacific (APAC) region has been an ongoing goal for Vetter. The company established its in Singapore in 2014, and subsequently formed a by opening an office in Tokyo in 2015. Although the pharmaceutical service provider had already been active in the South Korean market for years, the establishment of its own local branch office underlines the company''s commitment to the Asia Pacific market, particularly South Korea. With the new footprint, Vetter will be better positioned to support its existing South Korean business as well as that of new local and global customers, helping them to meet stringent development, manufacturing and packaging requirements of their injectable drugs.

"Today is yet another milestone for our company. This new office will allow us to directly serve both local and global companies with South Korean market interests," said Vetter Managing Director Peter Soelkner. "We are certain that our market presence and activities in this market will serve as an additional base and contribution for Vetter''s future global organic growth."



Headquartered in Ravensburg, Germany, Vetter is a global leading contract development and manufacturing organization (CDMO) with production facilities in Germany and the United States. The company has long-term experience offering ranging from early development support including , to and various for vials, syringes and cartridges. Vetter''s customers range from small and midsize to the world''s top 20 pharmaceutical and biotech companies. As a leading solution provider, the CDMO recognizes its responsibility in supporting the needs of its customers in developing devices that contribute to increased patient safety, convenience, and enhanced compliance. Learn more about Vetter at .





Image Available:



Vetter Pharma International GmbH
Markus Kirchner
Corporate Spokesperson / Specialist External Communications
Eywiesenstrasse 5
88212 Ravensburg
Germany
Phone: +49 (0)751-3700-3729
E-mail:

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  The CIIT Center Managed By Patient Access Solutions, Inc. Announces Hiring of Dr. Robert Goldman, Psy.D., J.D.
International Stem Cell Corporation Announces Positive Interim Clinical Results for Parkinson''s Disease Clinical Trial
Bereitgestellt von Benutzer: Marketwired
Datum: 09.11.2017 - 20:00 Uhr
Sprache: Deutsch
News-ID 1528162
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

SONGDO, SOUTH KOREA and RAVENSBURG, GERMANY


Phone:

Kategorie:

Alternative


Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:


Diese Pressemitteilung wurde bisher 1220 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Vetter expands its footprint in Asia Pacific region
"
steht unter der journalistisch-redaktionellen Verantwortung von

Vetter Pharma International GmbH (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Vetter Pharma International GmbH



 

Who is online

All members: 10 561
Register today: 2
Register yesterday: 2
Members online: 0
Guests online: 76


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.